Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RAVULIZUMAB vs REBAMIPIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RAVULIZUMAB vs REBAMIPIDE: Safety Overview

Metric RAVULIZUMAB REBAMIPIDE
Total FAERS Reports 118 427
Deaths Reported 11 32
Death Rate 9.3% 7.5%
Hospitalizations 89 222
Average Patient Age 48.4 yrs 63.7 yrs
% Female Patients 56.3% 56.6%
Manufacturer Alexion Pharmaceuticals Inc. N/A
Route INTRAVENOUS N/A